Skip to main content
// //
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 185.75
Day High 191.05
Open:191.05
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Stryker announces pricing of $2.3 billion senior notes offering
- GlobeNewswire - Tue May 26, 4:45PM CDT
GlobeNewswire - CMTX
Tue May 26, 4:45PM CDT
Stryker (NYSE:SYK) (the "Company") announced today that it has priced the following senior notes: (i) $650 million aggregate principal amount of the Company's 1.150% Notes due 2025 (the "2025 Notes"), (ii) $1 billion aggregate principal amount of the Company's 1.950% Notes due 2030 (the "2030 Notes"), and (iii) $650 million aggregate principal amount of the Company's 2.900% Notes due 2050 (the "2050 Notes" and, collectively with the 2025 Notes and the 2030 Notes, the "Notes"). Unless previously redeemed pursuant to their terms, if applicable, the 2025 Notes will mature on June 15, 2025, the 2030 Notes will mature on June 15, 2030, and the 2050 Notes will mature on June 15, 2050. The offering of the Notes is expected to settle on June 4, 2020, subject to the satisfaction of customary closing conditions.
RTI Surgical Holdings, Inc.(R) Appoints Stuart F. Simpson to Board of Directors
- GlobeNewswire - Tue May 26, 3:15PM CDT
GlobeNewswire - CMTX
Tue May 26, 3:15PM CDT
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced the appointment of Stuart F. Simpson as an independent member of its board of directors.
The Global Platelet Rich Plasma Market is expected to grow from USD 210.30 Million in 2018 to USD 489.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.81%
- PR Newswire - PRF - Thu May 14, 8:30AM CDT
PR Newswire - PRF - CMTX
Thu May 14, 8:30AM CDT
, /PRNewswire/ -- The Global Platelet Rich Plasma Market is expected to grow from in 2018 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.81%. Read the full report: The positioning of the Global Platelet Rich Plasma Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Platelet Rich Plasma Market including are Arthrex, Inc., Depuy Synthes, Inc, Harvest Technologies Corporation, Stryker Corporation, Zimmer Biomet, Adistem Ltd., Cesca Therapeutics, Inc., Eclipse Aesthetics, LLC, Emcyte Corporation, and Estar Technologies Ltd.. On the basis of Source Type, the Global Platelet Rich Plasma Market is studied across Allogenic, Autologous, and Homologous.On the basis of Application, the Global Platelet Rich Plasma Market is studied across Cosmetic Surgery, General Surgery, Neurosurgery, and Orthopedic Surgery.For the detailed coverage of the study, the market has been geographically divided into the Americas, , and , & . The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Platelet Rich Plasma Market 2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Platelet Rich Plasma Market 3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Platelet Rich Plasma Market 4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Platelet Rich Plasma Market 5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Platelet Rich Plasma Market 1. What is the market size of Platelet Rich Plasma market in the Global?2. What are the factors that affect the growth in the Global Platelet Rich Plasma Market over the forecast period?3. What is the competitive position in the Global Platelet Rich Plasma Market?4. Which are the best product areas to be invested in over the forecast period in the Global Platelet Rich Plasma Market?5. What are the opportunities in the Global Platelet Rich Plasma Market?6. What are the modes of entering the Global Platelet Rich Plasma Market?Read the full report: About ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 174.46 +6.79% increase
on 05/14/20
Period Open:188.12
Price movement based on the high, low and last over the given period.
196.32 -5.10% decrease
on 05/08/20
-1.82 (-0.97%) decrease
since 04/24/20
3-Month 124.54 +49.59% increase
on 03/23/20
Period Open:201.66
Price movement based on the high, low and last over the given period.
202.16 -7.85% decrease
on 02/27/20
-15.36 (-7.62%) decrease
since 02/26/20
52-Week 124.54 +49.59% increase
on 03/23/20
Period Open:184.77
Price movement based on the high, low and last over the given period.
226.30 -17.68% decrease
on 02/19/20
+1.53 (+0.83%) increase
since 05/24/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies